SCHEMBL5046589

SCHEMBL5046589

COC(=O)c1ccc(C(=O)NC(C)c2ccc(Br)s2)s1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
HDAC3 O15379 4/20 0.48
HDAC4 P56524 4/20 0.48
HDAC1 Q13547 4/20 0.48
SMN1; SMN2 Q16637 2/20 0.45
HPGD P15428 1/20 0.45
NPSR1 Q6W5P4 3/20 0.45
PPARG P37231 2/20 0.45
NCOA1 Q15788 2/20 0.45
NCOA3 Q9Y6Q9 2/20 0.45
HDAC6 Q9UBN7 4/20 0.44
USP2 O75604 1/20 0.43
MAPK1 P28482 1/20 0.43
HSD17B10 Q99714 1/20 0.43
LMNA P02545 1/20 0.40
NCOA2 Q15596 1/20 0.40
KDM4E B2RXH2 2/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5046005 0.80 HDAC3 (0.59) ALDH1A1L3MBTL1HDAC3HDAC4HDAC1
SCHEMBL5046007 0.80 HDAC3 (0.59) ALDH1A1L3MBTL1HDAC3HDAC4HDAC1
SCHEMBL1588287 0.79 NPSR1 (0.51) ALDH1A1L3MBTL1HDAC3HDAC4HDAC1
SCHEMBL6030315 0.78 ALDH1A1 (0.51) ALDH1A1L3MBTL1HDAC3HDAC4HDAC1
SCHEMBL70702 0.77 DAO (0.63) ALDH1A1L3MBTL1HPGDNPSR1PPARG
SCHEMBL6030810 0.76 HDAC3 (0.76) ALDH1A1L3MBTL1HDAC3HDAC4HDAC1
SCHEMBL6030805 0.76 HDAC3 (0.76) ALDH1A1L3MBTL1HDAC3HDAC4HDAC1
SCHEMBL5046183 0.76 HDAC6 (0.48) ALDH1A1L3MBTL1HDAC3HDAC4HDAC1
SCHEMBL13753379 0.76 ALDH1A1 (0.63) ALDH1A1L3MBTL1HDAC3HDAC4HDAC1
SCHEMBL5047907 0.75 HDAC3 (0.58) ALDH1A1L3MBTL1HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7396944-B2 Thiophene derivatives, their manufacture and use as pharmaceutical agents HOFFMANN-LA ROCHE INC. (US) 2008-07-08 US disclosed
US-20070232602-A1 Thiophene Derivatives, Their Manufacture and Use as Pharmaceutical Agents HOFFMAN-LA ROCHE INC. 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232602-A1 Thiophene Derivatives, Their Manufacture and Use as Pharmaceutical Agents TPMT, ABCB1, CYP3A5 ALDH1A1 129/4885L3MBTL1 3382/4885HDAC3 3854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.